Targeting Trypanosoma cruzi Sterol 14α-Demethylase (CYP51)
- 4 August 2011
- book chapter
- review article
- Published by Elsevier BV in Advances in Parasitology
- Vol. 75, 65-87
- https://doi.org/10.1016/b978-0-12-385863-4.00004-6
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Structural basis for conservation in the CYP51 familyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human Pathogen Trypanosoma cruziOnline Journal of Public Health Informatics, 2010
- Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human InfectionsOnline Journal of Public Health Informatics, 2010
- Indomethacin Amides as a Novel Molecular Scaffold for Targeting Trypanosoma cruzi Sterol 14α-DemethylaseJournal of Medicinal Chemistry, 2009
- Rational Modification of a Candidate Cancer Drug for Use Against Chagas DiseaseJournal of Medicinal Chemistry, 2009
- CYP51: A Major Drug Target in the Cytochrome P450 SuperfamilyLipids, 2008
- Sterol 14α-Demethylase as a Potential Target for Antitrypanosomal Therapy: Enzyme Inhibition and Parasite Cell GrowthCell Chemical Biology, 2007
- Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdomsBiochimica et Biophysica Acta (BBA) - General Subjects, 2007
- The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugsProceedings of the National Academy of Sciences of the United States of America, 2006
- Regulation of the mevalonate pathwayNature, 1990